Candidates for Treatment of Novel Corona virus disease, COVID-19: Current Scenario and Way Forwards
Clinical Oncology Research and Reports · 2021
DOI: 10.31579/2693-4787/016 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Oncology Research and Reports, 2021. Verfasst von Abu Bashar.
Abstract (Originalsprache)
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of coronavirus disease 2019 (COVID-19), has spread across the globe resulting in a pandemic affecting 215 countries. At the time of this review, COVID-19 has been diagnosed in more than 15,000,000 patients and associated with over 1,00,000 deaths globally (Canters for Disease Control and Prevention, World Health Organization). In this review, we herein summarize the current evidence as on June 15, 2020 to provide guidance on potential drugs for COVID-19 treatment or prophylaxis, their scientific rationale and their clinical efficacy and safety. New data continue to emerges daily regarding clinical characteristics, treatment options, and outcomes for COVID-19. Optimized supportive care remains the mainstay of therapy, and the clinical efficacy for the potential therapeutic agents is still under investigation.
Zitieren
APA
Bashar, A. (2021). Candidates for Treatment of Novel Corona virus disease, COVID-19: Current Scenario and Way Forwards. Clinical Oncology Research and Reports. https://doi.org/10.31579/2693-4787/016
Vancouver
Bashar A. Candidates for Treatment of Novel Corona virus disease, COVID-19: Current Scenario and Way Forwards. Clinical Oncology Research and Reports. 2021. doi:10.31579/2693-4787/016
BibTeX
@article{Bashar2021,
author = {Bashar, Abu},
title = {Candidates for Treatment of Novel Corona virus disease, COVID-19: Current Scenario and Way Forwards},
journal = {Clinical Oncology Research and Reports},
year = {2021},
doi = {10.31579/2693-4787/016}
}
EUVIMED